Inversion of the stereochemical configuration (3S, 5S)-clavaminic acid into (3R, 5R)-clavulanic acid: A computationally-assisted approach based on experimental evidence
- PMID: 26835563
- DOI: 10.1016/j.jtbi.2016.01.028
Inversion of the stereochemical configuration (3S, 5S)-clavaminic acid into (3R, 5R)-clavulanic acid: A computationally-assisted approach based on experimental evidence
Abstract
Clavulanic acid (CA), a potent inhibitor of β-lactamase enzymes, is produced by Streptomyces clavuligerus (Sc) cultivation processes, for which low yields are commonly obtained. Improved knowledge of the clavam biosynthetic pathway, especially the steps involved in the inversion of 3S-5S into 3R-5R stereochemical configuration, would help to eventually identify bottlenecks in the pathway. In this work, we studied the role of acetate in CA biosynthesis by a combined continuous culture and computational simulation approach. From this we derived a new model for the synthesis of N-acetyl-glycyl-clavaminic acid (NAG-clavam) by Sc. Acetylated compounds, such as NAG-clavam and N-acetyl-clavaminic acid, have been reported in the clavam pathway. Although the acetyl group is present in the β-lactam intermediate NAG-clavam, it is unknown how this group is incorporated. Hence, under the consideration of the experimentally proven accumulation of acetate during CA biosynthesis, and the fact that an acetyl group is present in the NAG-clavam structure, a computational evaluation of the tentative formation of NAG-clavam was performed for the purpose of providing further understanding. The proposed reaction mechanism consists of two steps: first, acetate reacts with ATP to produce a reactive acylphosphate intermediate; second, a direct nucleophilic attack of the terminal amino group of N-glycyl-clavaminic on the carbonyl carbon of the acylphosphate intermediate leads to a tetrahydral intermediate, which collapses and produces ADP and N-acetyl-glycyl-clavaminic acid. The calculations suggest that for the proposed reaction mechanism, the reaction proceeds until completion of the first step, without the direct action of an enzyme, where acetate and ATP are involved. For this step, the computed activation energy was ≅2.82kcal/mol while the reaction energy was ≅2.38kcal/mol. As this is an endothermic chemical process with a relatively small activation energy, the reaction rate should be considerably high. The calculations offered in this work should not be considered as a definite characterization of the potential energy surface for the reaction between acetate and ATP, but rather as a first approximation that provides valuable insight about the reaction mechanism. Finally, a complete route for the inversion of the stereochemical configuration from (3S, 5S)-clavaminic acid into (3R, 5R)-clavulanic acid is proposed, including a novel alternative for the double epimerization using proline racemase and NAG-clavam formation.
Keywords: Accumulation; Acetate; Clavulanic acid; N-acetyl-glycyl-clavaminic acid; Potential energy surface; Reaction mechanism.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
ORF17 from the clavulanic acid biosynthesis gene cluster catalyzes the ATP-dependent formation of N-glycyl-clavaminic acid.J Biol Chem. 2006 Jan 6;281(1):279-87. doi: 10.1074/jbc.M507711200. Epub 2005 Oct 26. J Biol Chem. 2006. PMID: 16251194
-
Biosynthesis and molecular genetics of clavulanic acid.Antonie Van Leeuwenhoek. 1999 Jan-Feb;75(1-2):125-33. doi: 10.1023/a:1001755724055. Antonie Van Leeuwenhoek. 1999. PMID: 10422585 Review.
-
Transcriptional Studies on a Streptomyces clavuligerus oppA2 Deletion Mutant: N-Acetylglycyl-Clavaminic Acid Is an Intermediate of Clavulanic Acid Biosynthesis.Appl Environ Microbiol. 2018 Oct 30;84(22):e01701-18. doi: 10.1128/AEM.01701-18. Print 2018 Nov 15. Appl Environ Microbiol. 2018. PMID: 30194098 Free PMC article.
-
Biosynthesis of clavam metabolites.J Ind Microbiol Biotechnol. 2012 Oct;39(10):1407-19. doi: 10.1007/s10295-012-1191-0. Epub 2012 Sep 5. J Ind Microbiol Biotechnol. 2012. PMID: 22948564 Review.
-
Ro 22-5417, a new clavam antibiotic from Streptomyces clavuligerus. III. Absolute stereochemistry.J Antibiot (Tokyo). 1983 Mar;36(3):217-25. doi: 10.7164/antibiotics.36.217. J Antibiot (Tokyo). 1983. PMID: 6833142
Cited by
-
Comparative Transcriptome Analysis of Streptomyces Clavuligerus in Response to Favorable and Restrictive Nutritional Conditions.Antibiotics (Basel). 2019 Jul 19;8(3):96. doi: 10.3390/antibiotics8030096. Antibiotics (Basel). 2019. PMID: 31330947 Free PMC article.
-
Bibliometric Analysis of Global Research on Clavulanic Acid.Antibiotics (Basel). 2018 Nov 26;7(4):102. doi: 10.3390/antibiotics7040102. Antibiotics (Basel). 2018. PMID: 30486255 Free PMC article.
-
Robustifying Experimental Tracer Design for13C-Metabolic Flux Analysis.Front Bioeng Biotechnol. 2021 Jun 22;9:685323. doi: 10.3389/fbioe.2021.685323. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34239861 Free PMC article.
-
Data of clavulanic acid and clavulanate-imidazole stability at low temperatures.Data Brief. 2019 Mar 7;23:103775. doi: 10.1016/j.dib.2019.103775. eCollection 2019 Apr. Data Brief. 2019. PMID: 31372423 Free PMC article.
-
TCA Cycle and Its Relationship with Clavulanic Acid Production: A Further Interpretation by Using a Reduced Genome-Scale Metabolic Model of Streptomyces clavuligerus.Bioengineering (Basel). 2021 Jul 22;8(8):103. doi: 10.3390/bioengineering8080103. Bioengineering (Basel). 2021. PMID: 34436106 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials